finance

Eli Lilly stock hits new high after successful drug study. Here's how the pros are playing it




READ SOURCE

Readers Also Like:  Market vulnerabilities and a possible U.S. recession: Strategists give cautious predictions for 2024

This website uses cookies. By continuing to use this site, you accept our use of cookies.